applying molecular understanding of dlbcl to management strategies
Published 4 years ago • 48 plays • Length 3:04Download video MP4
Download video MP3
Similar videos
-
1:52
an insight into the optimal management of patients with dlbcl
-
2:21
the role of molecular subtyping in dlbcl and implications for treatment decisions
-
0:37
the importance of diagnosing dlbcl on a molecular level and how it will improve treatment
-
2:03
novel treatment approaches for early-stage dlbcl
-
10:07
understanding diffuse large b-cell lymphoma with bruce cheson, md, facp, faaas, fasco
-
29:38
dlbcl treatment approaches: what you need to know
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
1:38
molecular subtypes in diffuse large b-cell lymphoma
-
1:45
improving the frontline treatment of dlbcl
-
7:16
changes in the classification of dlbcl
-
1:00
using molecular features to determine appropriate treatment strategies for patients with cll
-
1:34
molecular-guided treatment of b-cell lymphomas
-
3:39
the role of novel therapies in r/r dlbcl
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
5:30
how the treatment landscape of dlbcl is changing: r-chop vs pola-r-chp
-
1:45
how should we utilizing molecular data to improve all treatment?
-
3:58
phase ib/iia study of azd4573 acalabrutinib in r/r dlbcl
-
1:34
updated bsh guidelines for managing dlbcl
-
4:01
first- and second-line treatment in dlbcl
-
0:42
targeted therapies for dlbcl treatment
-
1:33
the difficulties of mrd detection in dlbcl